Efficiency of knockdown was proven via quantitative real-time PCR and Western Blot analysis (Figure 2A).We next sought to evaluate the influence of SFRP1 knockdown to standard triple negative breast cancer chemotherapy. This evidence concerns the gene SFRP1 and triple-negative breast carcinoma.